52-year-old man with liver enzyme abnormalities and elevated ferritin level.
作者信息
Nelsen Eric M, Newman Darrell B, Sweetser Seth
机构信息
Mayo School of Graduate Medical Education, Mayo Clinic, Rochester, MN, USA.
出版信息
Mayo Clin Proc. 2012 Jan;87(1):94-7. doi: 10.1016/j.mayocp.2011.08.004.
Abstract
摘要
相似文献
1
52-year-old man with liver enzyme abnormalities and elevated ferritin level.
Mayo Clin Proc. 2012 Jan;87(1):94-7. doi: 10.1016/j.mayocp.2011.08.004.
2
Why vitamin D status should be checked in patients with nonalcoholic fatty liver disease.为何要对非酒精性脂肪性肝病患者进行维生素D水平检测。
Mayo Clin Proc. 2012 Aug;87(8):808; author reply 808-9. doi: 10.1016/j.mayocp.2012.02.026.
3
[Study of patients referred for elevated ferritin levels and/or transferrin saturation: significance of non-alcoholic fatty liver disease].
Gastroenterol Hepatol. 2004 Nov;27(9):508-14. doi: 10.1016/s0210-5705(03)70517-2.
4
Usefulness of Magnetic Resonance Imaging for the Diagnosis of Hemochromatosis with Severe Hepatic Steatosis in Nonalcoholic Fatty Liver Disease.磁共振成像在诊断非酒精性脂肪性肝病合并严重肝脂肪变性的血色素沉着症中的应用价值
Intern Med. 2016;55(17):2413-7. doi: 10.2169/internalmedicine.55.6650. Epub 2016 Sep 1.
5
Clinical pearls in gastroenterology.
Dis Mon. 2018 Aug;64(8):361-369. doi: 10.1016/j.disamonth.2018.05.003. Epub 2018 Jun 5.
6
[Rare, but important chronic liver diseases].[罕见但重要的慢性肝病]
Praxis (Bern 1994). 2002 Nov 27;91(48):2077-85. doi: 10.1024/0369-8394.91.48.2077.
7
Fatty liver in H63D homozygotes with hyperferritinemia.H63D纯合子伴高铁蛋白血症的脂肪肝。
World J Gastroenterol. 2006 Mar 21;12(11):1788-92. doi: 10.3748/wjg.v12.i11.1788.
8
[Hemochromatosis or hemosiderosis? Initial misinterpretation of clinical symptoms and laboratory findings in a 62-year-old patient].[血色素沉着症还是含铁血黄素沉着症？一名62岁患者临床症状和实验室检查结果的初步误诊]
Z Gastroenterol. 2002 Apr;40(4):249-54. doi: 10.1055/s-2002-25148.
9
Serum hyaluronic acid with serum ferritin accurately predicts cirrhosis and reduces the need for liver biopsy in C282Y hemochromatosis.血清透明质酸联合血清铁蛋白可准确预测C282Y型血色素沉着症患者的肝硬化情况，并减少肝脏活检的必要性。
Hepatology. 2009 Feb;49(2):418-25. doi: 10.1002/hep.22650.
10
[Clinical experience with early hemochromatosis].
Tidsskr Nor Laegeforen. 1994 Jun 10;114(15):1704-8.
引用本文的文献
1
Deranged Liver Function Tests Associated With Hyperferritinemia in a Patient With Type 2 Diabetes Mellitus: A Case Study and Literature Review.2型糖尿病患者铁蛋白血症伴肝功能检查异常：病例报告与文献综述
Cureus. 2024 Aug 3;16(8):e66074. doi: 10.7759/cureus.66074. eCollection 2024 Aug.
2
Why vitamin D status should be checked in patients with nonalcoholic fatty liver disease.为何要对非酒精性脂肪性肝病患者进行维生素D水平检测。
Mayo Clin Proc. 2012 Aug;87(8):808; author reply 808-9. doi: 10.1016/j.mayocp.2012.02.026.
本文引用的文献
1
Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008.美国 1988 年至 2008 年最常见慢性肝病病因的流行率变化。
Clin Gastroenterol Hepatol. 2011 Jun;9(6):524-530.e1; quiz e60. doi: 10.1016/j.cgh.2011.03.020. Epub 2011 Mar 25.
2
Diagnosis and management of hereditary haemochromatosis.遗传性血色素沉着症的诊断与管理
BMJ. 2011 Jan 19;342:c7251. doi: 10.1136/bmj.c7251.
3
Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease.非酒精性脂肪性肝病患者的心血管疾病风险
N Engl J Med. 2010 Sep 30;363(14):1341-50. doi: 10.1056/NEJMra0912063.
4
Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based study.代谢综合征的各个组分是慢性肝病患者死亡的独立预测因子：一项基于人群的研究。
Gut. 2010 Oct;59(10):1410-5. doi: 10.1136/gut.2010.213553. Epub 2010 Jul 26.
5
Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis.吡格列酮、维生素 E 或安慰剂治疗非酒精性脂肪性肝炎。
N Engl J Med. 2010 May 6;362(18):1675-85. doi: 10.1056/NEJMoa0907929. Epub 2010 Apr 28.
6
Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis.非酒精性脂肪性肝炎纤维化进展危险因素的系统评价
J Hepatol. 2009 Aug;51(2):371-9. doi: 10.1016/j.jhep.2009.03.019. Epub 2009 May 3.
7
Pathways underlying iron accumulation in human nonalcoholic fatty liver disease.人类非酒精性脂肪性肝病中铁蓄积的潜在机制。
Am J Clin Nutr. 2008 May;87(5):1374-83. doi: 10.1093/ajcn/87.5.1374.
8
Non-alcoholic fatty liver disease in the Asia-Pacific region: definitions and overview of proposed guidelines.亚太地区的非酒精性脂肪性肝病：定义及拟议指南概述
J Gastroenterol Hepatol. 2007 Jun;22(6):778-87. doi: 10.1111/j.1440-1746.2007.05001.x.
9
Long-term follow-up of patients with NAFLD and elevated liver enzymes.非酒精性脂肪性肝病（NAFLD）及肝酶升高患者的长期随访
Hepatology. 2006 Oct;44(4):865-73. doi: 10.1002/hep.21327.
10
Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH.严重肥胖症患者脂肪组织中铁调素表达增加与糖尿病和非酒精性脂肪性肝炎无关。
Gastroenterology. 2006 Sep;131(3):788-96. doi: 10.1053/j.gastro.2006.07.007.
Zotero 插件